Retracted: Studi Literatur: Status Infeksi Tuberkulosis dan Progresi Penyakit HIV

Authors

  • Umi Solekhah Universitas Negeri Malang
  • Rara Warih Gayatri Universitas Negeri Malang
  • Tika Dwi Tama Universitas Negeri Malang

DOI:

https://doi.org/10.17977/um062v3i92021p745-756

Keywords:

tuberculosis infection status, HIV, disease progression, status infeksi tuberkulosis, progresi penyakit

Abstract

This paper has been withdrawn at the request of the author and has been retracted.

References

Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., … Lortholary, O. (2004). Tuberculosis in HIV-infected patients: A comprehensive review. Clinical Microbiology and Infection, 10(5), 388–398. https://doi.org/10.1111/j.1469-0691.2004.00758.x

Affusim, C., Abah, V., Kesieme, E. B., Anyanwu, K., Salami, T. A. T., & Eifediyi, R. (2013). The Effect of Low CD4+ Lymphocyte Count on the Radiographic Patterns of HIV Patients with Pulmonary Tuberculosis among Nigerians. Tuberculosis Research and Treatment, 2013, e535769. https://doi.org/10.1155/2013/535769

Ajmala, I. E., & Wulandari, L. (2015). Terapi ARV pada Penderita Ko-Infeksi TB-HIV. Jurnal Respirasi, 1(1), 22–28. https://doi.org/10.20473/jr.v1-I.1.2015.22-28

Astari, L., & Safitri, Y. E. (2009). Viral Load pada Infeksi HIV (Viral Load in HIV Infection). 21(1), 9.

Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., … Hardy, A. (2018). The principles and methods behind EFSA’s Guidance on Uncertainty Analysis in Scientific Assessment. EFSA Journal, 16(1). https://doi.org/10.2903/j.efsa.2018.5122

Bruchfeld, J., Correia-Neves, M., & Källenius, G. (2015). Tuberculosis and HIV Coinfection. Cold Spring Harbor Perspectives in Medicine, 5(7), a017871. https://doi.org/10.1101/cshperspect.a017871

Budiarti, R. (2018). HIV Infection: Immunopathogenesis and Risk Factor to Fishermen. Oceana Biomedicina Journal, 1(1), 25–43. https://doi.org/10.30649/obj.v1i1.4

Chaisson, R. E., Gallant, J. E., Keruly, J. C., & Moore, R. D. (1998). Impact of opportunistic disease on survival in patients with HIV infection. AIDS, 12(1), 29–33.

da Silva, T. P., Giacoia-Gripp, C. B. W., Schmaltz, C. A., Anna, F. M. S., Rolla, V., & Morgado, M. G. (2013). T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens. e66095. https://doi.org/10.1371/journal.pone.0066095

Dessie, Z. G., Zewotir, T., Mwambi, H., & North, D. (2020). Modelling HIV disease process and progression in seroconversion among South Africa women: Using transition-specific parametric multi-state model. Theoretical Biology and Medical Modelling, 17(1), 10. https://doi.org/10.1186/s12976-020-00128-5

Dheda, K., Lampe, F. C., Johnson, M. A., & Lipman, M. C. (2004). Outcome of HIV-Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases, 190(9), 1670–1676. https://doi.org/10.1086/424676

Gupta, V., & Gupta, S. (2004). Laboratory markers associated with progression of HIV infection. Indian Journal of Medical Microbiology, 22(1), 7.

Lagat, K. (2018). FACTORS LEADING TO FASTER PROGRESSION OF HIV TO AIDS. 69.

Li, C.-X., Li, Y.-Y., He, L.-P., Kou, J., Bai, J.-S., Liu, J., … Kuang, Y.-Q. (2019). The predictive role of CD4+ cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: An eight-year observation in China. BMC Immunology, 20(1), 31. https://doi.org/10.1186/s12865-019-0311-2

MacNeil, A. (2020). Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets—Worldwide, 2018. MMWR. Morbidity and Mortality Weekly Report, 69. https://doi.org/10.15585/mmwr.mm6911a2

Martinson, N. A., Gupte, N., Msandiwa, R., Moulton, L. H., Barnes, G. L., Ram, M., … Chaisson, R. E. (2014). CD4 and Viral Load Dynamics in Antiretroviral-Naïve HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort. PLoS ONE, 9(5). https://doi.org/10.1371/journal.pone.0096369

Musa, B. M., Musa, B., Muhammed, H., Ibrahim, N., & Musa, A. G. (2015). Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria. Annals of Thoracic Medicine, 10(3), 185–192. https://doi.org/10.4103/1817-1737.160838

National Heart, Lung, and Blood Institute. (2020). Study Quality Assessment Tools | NHLBI, NIH. Diambil 9 November 2020, dari https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools

Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012). Tuberculosis and HIV Co-Infection. PLOS Pathogens, 8(2), e1002464. https://doi.org/10.1371/journal.ppat.1002464

Périssé, A. R. S., Smeaton, L., Chen, Y., Rosa, A. L., Walawander, A., Nair, A., … ACTG, P. E. A. R. L. S. study team of the. (2013). Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease. PLoS One, 8(12), e83643. http://dx.doi.org/10.1371/journal.pone.0083643

Puspitasari, E., Yunihastuti, E., Rengganis, I., & Rumende, C. M. (2016). Prediktor Mortalitas Pasien HIV/AIDS Rawat Inap. Jurnal Penyakit Dalam Indonesia, 3(1), 22–28. https://doi.org/10.7454/jpdi.v3i1.29

Roser, M., & Ritchie, H. (2018). HIV / AIDS. Our World in Data. Diambil dari https://ourworldindata.org/hiv-aids

Sanou, M., Ba /Ky, A., Neya, A., T Yonli, A., François, D., Ruelle, J., … Simporé, J. (2019). Study of Viral Load as A Predictive Marker of the Evolution of HIV Type 2 Infection in Burkina Faso. Acta Scientific Microbiology, 2(10), 91–95. https://doi.org/10.31080/ASMI.2019.02.0378

Shankar, E. M., Vignesh, R., Ellegård, R., Barathan, M., Chong, Y. K., Bador, M. K., … Larsson, M. (2014). HIV–Mycobacterium tuberculosis co-infection: A ‘danger-couple model’ of disease pathogenesis. Pathogens and Disease, 70(2), 110–118. https://doi.org/10.1111/2049-632X.12108

Siika, A. M., Yiannoutsos, C. T., Wools-Kaloustian, K. K., Musick, B. S., Mwangi, A. W., Diero, L. O., … Carter, J. E. (2013). Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy. PLOS ONE, 8(1), e53022. https://doi.org/10.1371/journal.pone.0053022

Sullivan, Z. A., Wong, E. B., Ndung’u, T., Kasprowicz, V. O., & Bishai, W. R. (2015). Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV. EBioMedicine, 2(4), 334–340. https://doi.org/10.1016/j.ebiom.2015.03.005

Swartz, M. K. (2011). The PRISMA Statement: A Guideline for Systematic Reviews and Meta-Analyses. Journal of Pediatric Health Care, 25(1), 1–2. https://doi.org/10.1016/j.pedhc.2010.09.006

Toossi, Z., Mayanja-Kizza, H., Hirsch, C. S., Edmonds, K. L., Spahlinger, T., Hom, D. L., … Whalen, C. W. (2001). Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients: Impact of pulmonary TB on HIV-1 disease. Clinical & Experimental Immunology, 123(2), 233–238. https://doi.org/10.1046/j.1365-2249.2001.01401.x

WHO. (2019, November 15). HIV/AIDS. Diambil 7 Maret 2020, dari https://www.who.int/news-room/fact-sheets/detail/hiv-aids

World Health Organization. (2019). Global tuberculosis report 2019. Diambil dari http://apps.who.int/iris

Yasin, N. M., Maranty, H., & Ningsih, W. R. (2011). Response to antiretroviral therapy undergone by HIV/AIDS patients. Indonesian Journal of Pharmacy, 0(0), 212–222. https://doi.org/10.14499/indonesianjpharm0iss0pp212-222

Published

06-10-2021

Issue

Vol. 3 No. 9 (2021)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 Generic License.